Dana-Farber Cancer Institute · 2 hours ago
Associate Director, OHRS
Dana-Farber Cancer Institute is a leader in life changing breakthroughs in cancer research and patient care. The Associate Director for Human Research Studies (OHRS) oversees operational activities supporting IRB review and human research protections, manages workflows, and partners with clinical research offices to resolve operational issues and improve human research protection programs.
CommunitiesHealth CareHealth DiagnosticsHospitalNon ProfitOncology
Responsibilities
Manage daily IRB operational workflows, queue management, and service levels
Develop and maintain training materials and work instructions
Identify and implement process and systems improvements using metrics and stakeholder feedback, coordinating with the Director to ensure consistency across the DF/HCC consortium
Lead development, maintenance, and communication of OHRS SOPs and work instructions; ensure alignment across DF/HCC partner institutions
Maintain policy consistency with federal human subject regulations, standards, and HIPAA
Oversee quality checks, corrective actions, and continuous improvement activities
Serve as an alternate IRB member; conduct expedited reviews and limited IRB reviews as applicable
Act as senior OHRS representative at IRB meetings; assist reviews and ensures compliance
Review IRB minutes for accuracy and regulatory sufficiency
Serve as an operational liaison to various DF/HCC research offices and study teams
Troubleshoot escalations (e.g., submission issues, clarification requests) and ensure timely, compliant resolution
Represent OHRS at internal committees/working groups (e.g., RIO working group) and external forums (e.g., PRIM&R, AAHRPP)
Communicate with clinical trial offices across the five Harvard institutions (e.g., BIDMC CCTO, MGH CCPO, DFCI CTO)
Translate regulatory updates into operational guidance for investigators and staff
May have direct supervision of a team of analysts
Hires, develops, and manages staff to achieve organizational goals
Sets clear expectations, delivers feedback, and monitors performance for quality, efficiency, and compliance with policies and procedures
Mentors staff, fosters career growth, and cultivates a positive and productive work environment
Lead or support special projects as assigned by OHRS leadership
Qualification
Required
Bachelor's degree
5 years of experience in a cancer center and/or working with an academic IRB or research office
Demonstrated expertise in application of federal regulations to clinical research
Demonstrated knowledge of HIPAA regulations as they relate to clinical research
In-depth knowledge of Federal, state, and local regulatory information regarding the protection of human subjects in biomedical research
Strong written and verbal communication skills necessary to allow productive communication between OHRS, DF/HCC Leadership, Investigators and other research personnel
Ability to interpret complex regulations and provide sound, practical guidance to investigators and staff
Problem solving, decision-making and analytical skills necessary to identify problems and proposed solutions and the ability to implement solutions
Ability to work independently and collaboratively in a matrixed, multi-institution environment
Strong ability to lead and develop others professionally
Ability to influence and persuade others across all levels of staff, internally and externally
Flexibility and motivation to work on special projects
Preferred
CIP certification preferred
Company
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute is a center dedicated to carrying out adult and pediatric cancer treatment activities and advanced research.
H1B Sponsorship
Dana-Farber Cancer Institute has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (148)
2024 (145)
2023 (155)
2022 (139)
2021 (105)
2020 (113)
Funding
Current Stage
Late StageTotal Funding
$88.08MKey Investors
Elaine and Eduardo Saverin FoundationThe DeGregorio Family FoundationLlama
2025-11-24Grant· $20M
2025-05-06Grant· $1M
2024-09-24Grant· $0.5M
Recent News
Medical Xpress - latest medical and health news stories
2025-12-29
MarketScreener
2025-12-16
Company data provided by crunchbase